BETULA VERRUCOSA ALLERGEN EXTRACT (Itulazax®)
Clinical Indication
Moderate to severe allergic rhinitis/conjunctivitis caused by Birch pollen
Date of classification
October 2023
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.